Current Advances in Osteosarcoma

Nonfiction, Health & Well Being, Medical, Medical Science, Microbiology, Specialties, Oncology
Cover of the book Current Advances in Osteosarcoma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319048437
Publisher: Springer International Publishing Publication: June 12, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319048437
Publisher: Springer International Publishing
Publication: June 12, 2014
Imprint: Springer
Language: English

Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.

More books from Springer International Publishing

Cover of the book Internet of Things and Big Data Analytics Toward Next-Generation Intelligence by
Cover of the book Public Brainpower by
Cover of the book Financing the Apocalypse by
Cover of the book Man-made Catastrophes and Risk Information Concealment by
Cover of the book Image Analysis and Recognition by
Cover of the book Ombudsmen and ADR by
Cover of the book Economic Transformation and Business Opportunities in Asia by
Cover of the book Learning and Collaboration Technologies. Design, Development and Technological Innovation by
Cover of the book Deterministic Abelian Sandpile Models and Patterns by
Cover of the book Energy Efficient Smart Phones for 5G Networks by
Cover of the book Advances in Computing by
Cover of the book Silicene by
Cover of the book Metallomics by
Cover of the book Disney and the Dialectic of Desire by
Cover of the book Medical and Biomedical Applications of Shock Waves by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy